Sudsawat Laohavinij

A Phase I clinical study of the antipurine antifolate lometrexol (DDATHF) given with oral folic acid

Sudsawat Laohavinij, Stephen R. Wedge, Micheal J. Lind et al. · Investigational New Drugs · 1996 · 50 citations

Translational Medicine, Pharmacology, Oral Folic Acid +3

A randomized, double-blind, placebo-controlled study evaluating the efficacy of combination olanzapine, ondansetron and dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients receiving doxorubicin plus cyclophosphamide

Piyawan Tienchaiananda, Wipada Nipondhkit, Kunlatida Maneenil et al. · Annals of Palliative Medicine · 2019 · 39 citations · Full text

Prognostic factors for survival in colorectal cancer patients.

Sudsawat Laohavinij, Jedzada Maneechavakajorn, Parapat Techatanol · PubMed · 2010 · 37 citations

Clinical pharmacokinetics of the antipurine antifolate (6R)-5,10- dideaza-5,6,7,8-tetrahydrofolic acid (Lometrexol) administered with an oral folic acid supplement.

Stephen R. Wedge, Sudsawat Laohavinij, G. A. Taylor et al. · PubMed · 1995 · 22 citations

Drug Safety, Molecular Pharmacology, Medicinal Chemistry +13

Phase II study of paclitaxel and carboplatin for advanced non-small-cell lung cancer

Sudsawat Laohavinij, S Maoleekoonpairoj, A Cheirsilpa et al. · Lung Cancer · 1999 · 21 citations

Medicine, Pharmacology, Phase Ii Study +5